Rabeprazole: pharmacology, pharmacokinetics, and potential for drug interactions. Introduction

Aliment Pharmacol Ther. 1999 Aug:13 Suppl 3:1-2. doi: 10.1046/j.1365-2036.1999.00018.x.

Authors

G Sachs¹, T J Humphries

Affiliation

¹ Department of Physiology and Medicine, University of California, Los Angeles, USA.

PMID: 10491722
DOI: 10.1046/j.1365-2036.1999.00018.x

No abstract available

MeSH terms

2-Pyridinylmethylsulfinylbenzimidazoles
Animals
Anti-Ulcer Agents / adverse effects
Anti-Ulcer Agents / pharmacokinetics
Anti-Ulcer Agents / pharmacology*
Anti-Ulcer Agents / therapeutic use
Benzimidazoles / adverse effects
Benzimidazoles / pharmacokinetics
Benzimidazoles / pharmacology*
Benzimidazoles / therapeutic use
Enzyme Inhibitors / adverse effects
Enzyme Inhibitors / pharmacokinetics
Enzyme Inhibitors / pharmacology*
Enzyme Inhibitors / therapeutic use
Humans
Omeprazole / analogs & derivatives
Proton Pump Inhibitors*
Rabeprazole

Substances

2-Pyridinylmethylsulfinylbenzimidazoles
Anti-Ulcer Agents
Benzimidazoles
Enzyme Inhibitors
Proton Pump Inhibitors
Rabeprazole
Omeprazole